Literature DB >> 1865994

Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a 5-hydroxytryptamine1A agonistic anxiolytic.

Y Kataoka1, K Shibata, A Miyazaki, Y Inoue, K Tominaga, S Koizumi, S Ueki, M Niwa.   

Abstract

The effect of tandospirone, a 5-hydroxytryptamine (5-HT)1A agonist/anxiolytic, injected directly into dorsal hippocampus, on Vogel-type conflict behavior in rats was investigated and the findings were compared with the effects of diazepam and zopiclone. Tandospirone (30 micrograms/2 microliters and 60 micrograms/2 microliters) and diazepam (40 micrograms/2 microliters) but not zopiclone (20 micrograms/2 microliters), produced a potent anticonflict action in rats. The anticonflict action of tandospirone (30 micrograms/2 microliters), injected into the dorsal hippocampus, was significantly blocked by (-)-propranolol (5 mg/kg i.p.). The present findings provide evidence that suggests that tandospirone has an antianxiety action, presumably by stimulating 5-HT1A receptors in the dorsal hippocampus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865994     DOI: 10.1016/0028-3908(91)90009-z

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice.

Authors:  Emily Freeman-Daniels; Sheryl G Beck; Lynn G Kirby
Journal:  Psychopharmacology (Berl)       Date:  2010-10-28       Impact factor: 4.530

Review 2.  Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.

Authors:  Yukihiro Ohno
Journal:  CNS Neurosci Ther       Date:  2010-11-21       Impact factor: 5.243

3.  Adolescent female rats exhibiting activity-based anorexia express elevated levels of GABA(A) receptor α4 and δ subunits at the plasma membrane of hippocampal CA1 spines.

Authors:  Chiye Aoki; Nicole Sabaliauskas; Tara Chowdhury; Jung-Yun Min; Anna Rita Colacino; Kevin Laurino; Nicole C Barbarich-Marsteller
Journal:  Synapse       Date:  2012-02-15       Impact factor: 2.562

4.  α4βδ-GABAARs in the hippocampal CA1 as a biomarker for resilience to activity-based anorexia.

Authors:  C Aoki; G Wable; T G Chowdhury; N A Sabaliauskas; K Laurino; N C Barbarich-Marsteller
Journal:  Neuroscience       Date:  2014-01-18       Impact factor: 3.590

5.  Voluntary Wheel Running Exercise Evoked by Food-Restriction Stress Exacerbates Weight Loss of Adolescent Female Rats But Also Promotes Resilience by Enhancing GABAergic Inhibition of Pyramidal Neurons in the Dorsal Hippocampus.

Authors:  Tara G Chowdhury; Gauri S Wable; Yi-Wen Chen; Kei Tateyama; Irene Yu; Jia-Yi Wang; Alex D Reyes; Chiye Aoki
Journal:  Cereb Cortex       Date:  2019-09-13       Impact factor: 5.357

6.  α4-GABAA receptors of hippocampal pyramidal neurons are associated with resilience against activity-based anorexia for adolescent female mice but not for males.

Authors:  Yi-Wen Chen; Hannah Actor-Engel; Chiye Aoki
Journal:  Mol Cell Neurosci       Date:  2018-04-22       Impact factor: 4.314

7.  Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) Receptors.

Authors:  Saki Shimizu; Yukihiro Ohno
Journal:  Aging Dis       Date:  2012-11-29       Impact factor: 6.745

8.  Adolescent female C57BL/6 mice with vulnerability to activity-based anorexia exhibit weak inhibitory input onto hippocampal CA1 pyramidal cells.

Authors:  T G Chowdhury; G S Wable; N A Sabaliauskas; C Aoki
Journal:  Neuroscience       Date:  2013-03-21       Impact factor: 3.590

9.  Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety.

Authors:  S S Smith; Q H Gong; X Li; M H Moran; D Bitran; C A Frye; F C Hsu
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

Review 10.  5-HT1A receptor agonists: recent developments and controversial issues.

Authors:  J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.